Estimates Revisions Compugen Ltd. TEL AVIV STOCK EXCHANGE
Stocks
CGEN
IL0010852080
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 591.70 ILa | +1.88% |
|
-4.67% | +26.43% |
| 05-18 | Compugen Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 05-18 | Compugen Files $400 Million Mixed Shelf | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| - | |||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
- Stock Market
- Stocks
- CGEN Stock
- CGEN Stock
- Consensus Compugen Ltd.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
